As attcahed.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 15.7 pts more than Nifty Microcap 250 and 15.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Archit Organosys Limited's Board has approved the standalone audited financial results for the quarter and year ended 31 March 2025. Revenue from operations for FY25 stood at Rs. 12,559.92 lacs, up from Rs. 11,319.14 lacs in FY24. Net profit for FY25 rose sharply to Rs. 505.11 lacs from Rs. 333.79 lacs in FY24. The Board has recommended a final dividend of Rs. 0.50 per equity share (5% on face value of Rs. 10). Additionally, Mr. Ajay P Patel has been appointed as the new Chief Financial Officer with immediate effect. The statutory auditor, G K Choksi & Co., issued an unmodified (clean) opinion on the financial results, and the company also filed a declaration confirming the same.
Net profit grew over 51% year-on-year, signalling a meaningful improvement in profitability for shareholders. The 5% final dividend and clean audit opinion reinforce confidence, while the new CFO appointment marks an important governance update that investors should monitor.